This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Novina CD, Sharp PA . The RNAi revolution. Nature 2004; 430: 161–164.
Kurzrock R, Kantarjian HM, Druker BJ, Talpaz M . Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics. Ann Intern Med 2003; 138: 819–830.
Wilda M, Fuchs U, Wossmann W, Borkhardt A . Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi). Oncogene 2002; 21: 5716–5724.
Scherr M, Battmer K, Winkler T, Heidenreich O, Ganser A, Eder M . Specific inhibition of bcr-abl gene expression by small interfering RNA. Blood 2003; 101: 1566–1569.
Wohlbold L, van der Kuip H, Miething C, Vornlocher HP, Knabbe C, Duyster J et al. Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571). Blood 2003; 102: 2236–2239.
Li MJ, McMahon R, Snyder DS, Yee JK, Rossi JJ . Specific killing of Ph+ chronic myeloid leukemia cells by a lentiviral vector-delivered anti-bcr/abl small hairpin RNA. Oligonucleotides 2003; 13: 401–409.
Kronenwett R, Haas R, Sczakiel G . Kinetic selectivity of complementary nucleic acids: bcr-abl-directed antisense RNA and ribozymes. J Mol Biol 1996; 259: 632–644.
Khvorova A, Reynolds A, Jayasena SD . Functional siRNAs and miRNAs exhibit strand bias. Cell 2003; 115: 209–216.
Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD . Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003; 115: 199–208.
Freier SM, Kierzek R, Jaeger JA, Sugimoto N, Caruthers MH, Neilson T et al. Improved free-energy parameters for predictions of RNA duplex stability. Proc Natl Acad Sci USA 1986; 83: 9373–9377.
Acknowledgements
This work was financially supported by the Robert Bosch foundation Project No. 11.5.8002.0006.1.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wohlbold, L., van der Kuip, H., Moehring, A. et al. All common p210 and p190 Bcr-abl variants can be targeted by RNA interference. Leukemia 19, 290–292 (2005). https://doi.org/10.1038/sj.leu.2403603
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403603
This article is cited by
-
RNAi-mediated silencing of p190Bcr-Abl inactivates Stat5 and cooperates with imatinib mesylate and 17-allylamino-17-demetoxygeldanamycin in selective killing of p190Bcr-Abl-expressing leukemia cells
Leukemia (2008)
-
Effects of siRNAs in combination with Gleevec on K-562 cell proliferation and Bcr-Abl expression
Journal of Biomedical Science (2006)